ODDB.org: Open Drug Database

Swissmedic Registration	67596	Date of registration	24.09.2020
Company name	Novartis Pharma Schweiz AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	03.04.50.	Revocation Date
Index Therapeuticus (Swissmedic)	03.04.50.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
02	Enerzair Breezhaler 150/50/160 μg	Hartkapsel mit Pulver zur Inhalation		R03AL12	CI

2025	©ywesee GmbH